By vgreene, 15 January, 2015 Anticoagulant (warfarin; apixaban, dabigatran, rivaroxaban)<sup>22</sup>
By vgreene, 15 January, 2015 Cath ablation<sup>19</sup> + peri-ablation anticoagulation<sup>17</sup> is an option; factor risk/benefit, pt preference.
By vgreene, 15 January, 2015 If undergoing cardiac surgery for other reasons: maze procedure reasonable for select pts<sup>19</sup> [IIa/C]
By vgreene, 15 January, 2015 Cath ablation of accessory pathway recommended for pre-excited AF<sup>19</sup> [I/C]
By vgreene, 15 January, 2015 Cath ablation<sup>19</sup> for persistent AF w/ sx reasonable if refractory/intolerant to ≥1 class I/III drug [IIa/A], consider for long-standing (>12 mo) persistent AF w/ sx [IIb/B]; consider as initial strategy before class I/III drug trial [IIb/B]
By vgreene, 15 January, 2015 Cath ablation<sup>19</sup> for paroxysmal AF w/ sx: useful if refractory/intolerant to ≥1 class I/III drug [I/A]; reasonable as initial strategy before class I/III drug trial for recurrent paroxysmal AF w/ sx [IIa/B]
By vgreene, 15 January, 2015 Postconversion drug maintenance options<sup>19</sup> based on CAD/LVH/HF, comorbidities, drug risks [I/A], +/- rate-control tx. OK to continue antiarrhythmic despite infrequent well-tolerated recurrences [IIb/C]; stop if AF becomes permanent [III/B]